The University of Chicago Header Logo

Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial.

Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial. Gastroenterology. 1999 Dec; 117(6):1271-7.

View in: PubMed